Grant: Team Grant: HIV/AIDS Vaccine Discovery and Social Research
University of Toronto
$1,165,418.00
CIHR team grant in HIV vaccine discovery: novel mechanisms and strategies of protection
EF 2011-12
Résumé
We currently have no effect vaccine for the prevention of HIV. Neither do we have a therapy that can completely cure HIV. The current team grant will combine the expertise of a team of cutting edge immunologists, translational biologists and biochemists at the University of Toronto, with clinical epidemiologists at the University of Nairobi Kenya, to uncover new avenues of research that may lead to an HIV vaccine. In addition, new ideas will be explored that can be used to treat HIV infection with the use of immunotherapies. It is hoped that cross-fertilization of expertises between Kenya and Canada will lead to new discoveries that can be applied to rapidly produce an HIV vaccine.
Programme
Team Grant: HIV/AIDS Vaccine Discovery and Social Research
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
234946
Name
Ostrowski Mario A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian International Development Agency
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
HIV/AIDS Vaccine Discovery and Social Research
Projecttitle
CIHR team grant in HIV vaccine discovery: novel mechanisms and strategies of protection
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$1,165,418
Cihrequipment2
$0
Programname2
Team Grant: HIV/AIDS Vaccine Discovery and Social Research
Keyworddelim
Adjuvants; Global Health; Hiv; Integrins; Mucosal Immunology; Neutralizing Antibody; Nod Like Receptors; T Cell Regulation; Tumor Necrosis Factor Superfamily; Vaccine Trials
Abstract
We currently have no effect vaccine for the prevention of HIV. Neither do we have a therapy that can completely cure HIV. The current team grant will combine the expertise of a team of cutting edge immunologists, translational biologists and biochemists at the University of Toronto, with clinical epidemiologists at the University of Nairobi Kenya, to uncover new avenues of research that may lead to an HIV vaccine. In addition, new ideas will be explored that can be used to treat HIV infection with the use of immunotherapies. It is hoped that cross-fertilization of expertises between Kenya and Canada will lead to new discoveries that can be applied to rapidly produce an HIV vaccine.
Competitiondate
201106
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Ostrowski, Mario A; Jaoko, Walter G
Approvedterm
5 ans 0 mois
Cihrcontribution2
HIV/AIDS~ $1,165,418~ $0~
